Abstract:ABSTRACT Chlamydia trachomatis (CT) is a significant sexually transmitted pathogen known to evoke severe complications, including infertility. Nucleic acid amplification tests (NAATs) are recommended by the World Health Organization to detect CT infection. Furthermore, the establishment of methods, performance validation, internal quality control, and external quality assessment for CT NAATs necessitate the utilization of quality control materials (QCs). QCs are specimens or solutions that are analyzed for quality control purposes in a test system. In this study, we established a novel cell line that stably integrates CT amplification target sequences for producing QCs for CT NAATs. Utilizing clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 technology, we integrated the CT plasmid-mediated sequence (comprising the full length of the cryptic plasmid and the major outer membrane protein gene, 9,136 bp) into the MUC4 gene of HEK293T cells. Positive clones were screened through flow cytometric sorting, single-cell culture, and PCR-based identification, followed by the establishment of stable cell lines. These cells were then processed using optimized cell preservation procedures to prepare QCs. The sequence insertion copy number was confirmed by real-time quantitative PCR. This novel CT QCs demonstrate excellent clinical applicability, non-infectiousness, quantifiability, and stability. With an integrated sequence exceeding 9 kb in length, it offers exceptional flexibility for adapting to new kit developments. Furthermore, maintaining a well-defined copy number and stable shelf life, the QCs closely aligns with the quality control requirements of CT NAATs. This study presents an innovative method for preparing QCs for CT nucleic acid detection, making a valuable contribution to improving the performance of CT NAATs. IMPORTANCE Untreated CT infections impose significant burdens on individuals and communities, underscoring the importance of early and accurate testing via CT NAATs for disease control. QCs are instrumental in identifying testing process issues. Hence, we developed a cell line integrating CT-amplified target sequences as readily accessible non-infectious QCs. These QCs boast several advantages: the integration of over 9 kb of CT sequence allows for broad applicability, allowing flexible adaptation to the development of new kits. Confirming the CT sequence copy number provides a reliable basis for QC concentration preparation and kit detection limit evaluation. Optimized preservation protocol enhances QC stability during storage, facilitating convenient shipment to clinical laboratories at ambient temperatures. In summary, our novel CT QCs offer a powerful tool for improving CT NAAT performance and present a fresh perspective on QC preparation for detecting nucleic acids from intracellular parasitic pathogens.

Highly reproducible and sensitive electrochemical biosensor for <i>Chlamydia trachomatis</i> detection based on duplex-specific nuclease-assisted target-responsive DNA hydrogels and bovine serum albumin carrier platform

Fluorescent Biosensor Based on Hairpin DNA Stabilized Copper Nanoclusters for Chlamydia trachomatis Detection

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

An Ultra-Sensitive CRISPR-Cas12a and Aptamer-Based Biosensor Utilizing Entropy-driven Catalytic DNA Networks for Precise Detection of DNA Methyltransferase 1

A DNA Electrochemical Biosensor Based on Homogeneous Hybridization for the Determination of Cryptococcus Neoformans

Target-induced Aptamer Displacement on Gold Nanoparticles and Rolling Circle Amplification for Ultrasensitive Live Salmonella Typhimurium Electrochemical Biosensing

Rapid 16S Rdna Electrochemical Sensor for Detection of Bacteria Based on the Integration of Target-Triggered Hairpin Self-Assembly and Tripedal DNA Walker Amplification.

A novel method for the preparation of reproducible, stable, and non-infectious quality control materials for Chlamydia trachomatis nucleic acid detection

Construction of ratiometric fluorescence sensor and test strip with smartphone based on dual-emission carbon dots for the specific detection of chlortetracycline

Highly Specific and Sensitive Sandwich-Type Electrochemiluminescence Biosensor for HPV16 DNA Detection Based on the Base-Stacking Effect and Bovine Serum Albumin Carrier Platform.

Development of a rapid real-time PCR assay for detection and quantification of four familiar species of Chlamydiaceae.

A Universal Electrochemical Biosensor Based on CRISPR/Cas12a and a DNA Tetrahedron for Ultrasensitive Nucleic Acid Detection

Plasmon Coupling Enhanced Raman Scattering Nanobeacon for Single-Step, Ultrasensitive Detection of Cholera Toxin

Highly Reproducible and Sensitive Electrochemiluminescence Biosensors for HPV Detection Based on Bovine Serum Albumin Carrier Platforms and Hyperbranched Rolling Circle Amplification

Addressing Challenges in Chlamydia trachomatis Detection: A Comparative Review of Diagnostic Methods

Novel and Sensitive Electrochemical/fluorescent Dual-Mode Biosensing Platform Based on the Cascaded Cyclic Amplification of Enzyme-Free DDSA and Functional Nucleic Acids.

Homogeneous Electrochemiluminescence Aptasensor Based on Hybridization Chain Reaction and Magnetic Separation Assistance for Staphylococcus Aureus

Ultrasensitive Electrochemical Detection of Mycobacterium Tuberculosis IS6110 Fragment Using Gold Nanoparticles Decorated Fullerene Nanoparticles/nitrogen-Doped Graphene Nanosheet As Signal Tags.

Development of a Real-Time PCR Assay for Detection and Quantitation of Chlamydia Using SYBR Green and the Light Cycler

Sensitive electrochemical detection of oxytetracycline based on target triggered CHA and poly adenine assisted probe immobilization

An Ultra-Sensitive Electrochemical Biosensor for Circulating Tumor DNA Utilizing Dual Enzyme-Assisted Target Recycle and Hybridization Chain Reaction Amplification Strategies